ArticleAsian Pacific journal of cancer prevention : APJCP2025
The Ideal Second-Line Treatment Options for Patients with Advanced Biliary Tract Cancer Refractory to Gemcitabine-Based First-Line Chemotherapy: A Result From Bayesian Network-Meta Analysis.
Erwin Syarifuddin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.